Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
Feng F, Tian Y, Xu G, Liu Z, Liu S, Zheng G, Guo M, Lian X, Fan D, Zhang H. · 2017
Read Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. by Feng F, Tian Y, Xu G, Liu Z, Liu S, Zheng G, Guo M, Lian X, Fan D, Zhang H. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5679342.txt.
Description
Feng and co-authors report a clinical study in BMC Cancer. It tests four tumor markers in early gastric cancer. The markers are CEA, CA19-9, AFP, and CA125. Their diagnostic and prognostic value here was unstudied. The cohort held 587 patients treated with radical gastrectomy. Records spanned September 2008 to March 2015. Marker levels were matched against clinical traits and survival.
Positive rates for single markers were low. CEA and CA19-9 each flagged under five percent of patients. AFP and CA125 flagged under two percent each. All four combined reached about ten percent. Raised CA19-9 tracked with female sex and node spread. Raised CEA independently predicted poorer prognosis.
Catalog record
| CREATOR | Feng F, Tian Y, Xu G, Liu Z, Liu S, Zheng G, Guo M, Lian X, Fan D, Zhang H. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |